Cancer drug firm names Pollett CFO
Biopharmaceutical firm Sellas has appointed financial management veteran Bill Pollett as its chief financial officer.
Sellas, which develops immunotherapeutic products to treat a variety of cancers, said they were pleased to attract a CFO with Mr Pollett’s experience.
Dr Angelos Stergiou, CEO of Sellas, added that Mr Pollett’s appointment would assist the company in becoming a leader in its field.
Mr Pollett added: “Having the opportunity to work for an innovative biopharmaceutical company that is on the verge of final-stage clinical testing is an exciting professional opportunity and especially unique in Bermuda.
“I look forward to helping the company grow in the new headquarters in Bermuda.”
Mr Pollett was formerly president and CEO of Blue Capital.
The good, the bad and the downright cowardly
Video assault suspects arrested
UK passport concerns are ‘hogwash’
Commission critics ‘driven by self-interest’
Woman denies racial intimidation charge
Bermuda-linked billionaires make Forbes list
Dog owner accused of cruelty
London lockdown after terror attack
Skyport takes flight
Charitable status set for review April 4
Companies to pay more for Bermuda ‘branch’
A lust for life
Island to reap America’s Cup telecoms legacy
Boats to race for first time
Man admits using stolen bank cards
Cheers! Relief for beer drinkers
Take Our Poll